Deroxen Foam Spray 200 ml Bottle
Cutaneous spray foam with chlorhexidine digluconate, allantoin and alpha-bisabolol for dogs and cats. Indicated for dermatitis, superficial and deep pyoderma, Malassezia infections and dermatophytosis. Antiseptic and soothing action. 200 ml bottle.
-
Express delivery: in 24/48 hours
Standard in 3-5 working days -
Shipping
Standard €6.50, express €9.00
Sardinia, Venice and minor islands: €20.00 -
Returns within 14 days
Right of withdrawal guaranteed -
Secure payments
Need help? Contact us
Description
Name
DEROXEN FOAM SPRAY, 4 MG/ML CUTANEOUS FOAM FOR DOGS AND CATS
Pharmacotherapeutic Category
Antiseptics and disinfectants; chlorhexidine, combinations.
Active Ingredients
100 ml of solution contain: active ingredients: chlorhexidine digluconate (equal to 0.4 g of chlorhexidine base) 0.71 g; allantoin 0.4 g; alpha-bisabolol 1 g. Excipients: for the full list of excipients, see section 6.1.
Excipients
Cocamidopropyl betaine, isopropyl alcohol, purified water.
Indications
For the treatment of skin diseases in dogs and cats in which it is necessary to ensure, topically, a drastic reduction of pathogenic germs while at the same time supporting repair processes; in particular: infections caused by Malassezia; superficial pyoderma such as intertrigo, impetigo, superficial folliculitis, pyotraumatic dermatitis; deep pyoderma such as furunculosis, canine acne, pododermatitis; seborrhoea associated with infections; dermatophytosis; and as a deodorant.
Contraindications/Side Effects
Do not use in animals with known hypersensitivity to the active ingredients or to any of the excipients. See also section 4.5. Do not use in suckling puppies and kittens.
Safety in the Target Species
Chlorhexidine digluconate, Allantoin and Bisabolol are contained in Deroxen Foam in modest quantities, making the administration of excessive doses very unlikely. Transcutaneous absorption of Chlorhexidine is nil, so the administration of an excessive dose of Deroxen Foam has no consequences. Thanks to its poor intestinal absorption, Chlorhexidine has low oral toxicity: the oral LD50 is 1.8 g/kg in mice. As regards the tolerability of Chlorhexidine digluconate, its extensive use in human and veterinary medicine has shown that only topical concentrations higher than 2% (equal to 11.2 mg/ml of Chlorhexidine base) can cause skin irritation and that concentrations up to 0.2% (equal to 1.12 mg/ml of Chlorhexidine base) are tolerated even for ophthalmic treatments.
Dosage
For external use only. Spray the foam and spread it evenly over the whole body of the animal or only over the parts to be treated, working it in until it reaches the skin if the animal has not been clipped. Depending on the length of the animal's coat, administer: 4 to 8 sprays/kg, corresponding to 11.5 mg and 23 mg of chlorhexidine base per kg of body weight respectively, for the 200 ml pack; 2 to 4 sprays/kg, corresponding to 12.5 mg and 25 mg of chlorhexidine base per kg of body weight respectively, for the 350 ml pack. At the end of treatment, the skin and coat should be evenly damp. Gently comb the animal if necessary. Do not dry. Repeat initially every day or every other day, then at longer intervals, at the discretion of the veterinary surgeon, until remission.
Storage
Store at room temperature and protected from light. Shelf life of the veterinary medicinal product as packaged for sale: 5 years.
Warnings
Use the medicine according to the directions for use. Prolonged use of topical products may give rise to sensitisation. In this case, stop treatment and consult a veterinary surgeon. Special precautions for use in animals: avoid using too much foam. Do not rinse. Do not dry with cloths or absorbent paper. Avoid contact with the eyes. Do not use at the same time as other cleansers. For external use only. Special precautions to be taken by the person administering the veterinary medicinal product to animals: people with known hypersensitivity to the active ingredients in this medicine should avoid contact with the veterinary medicinal product. Wearing gloves during use is recommended. Avoid contact with the eyes. In case of contact, rinse the eyes with plenty of water. Do not swallow. In case of accidental ingestion, seek medical advice immediately and show the doctor the package leaflet or the label. Chlorhexidine digluconate, Allantoin and Bisabolol are contained in Deroxen Foam in modest quantities, making the administration of excessive doses very unlikely. Transcutaneous absorption of Chlorhexidine is nil, so the administration of an excessive dose of Deroxen Foam has no consequences. Thanks to its poor intestinal absorption, Chlorhexidine has low oral toxicity: the oral LD50 is 1.8 g/kg in mice. As regards the tolerability of Chlorhexidine digluconate, its extensive use in human and veterinary medicine has shown that only topical concentrations higher than 2% (equal to 11.2 mg/ml of Chlorhexidine base) can cause skin irritation and that concentrations up to 0.2% (equal to 1.12 mg/ml of Chlorhexidine base) are tolerated even for ophthalmic treatments. Surfactants other than the one contained in Deroxen Foam may cancel out the germicidal activity of Chlorhexidine; do not use at the same time as other cleansers or topical solutions containing borates, bicarbonates, carbonates, chlorides, citrates, nitrates, phosphates or sulphates.
Withdrawal Periods
Not applicable.
Target Species
Dogs and cats.
Interactions
Do not use at the same time as other antiseptics. See section 6.2.
Diagnosis and Prescription
Veterinary medicinal product not subject to veterinary prescription. Use after consulting a veterinary surgeon is recommended.
Side Effects
In rare cases, animals may develop skin irritation after treatment.
Pregnancy and Lactation
Chlorhexidine is not absorbed through the skin and gastrointestinal absorption in case of ingestion is practically nil. The product can be used during pregnancy and lactation.
Product Details
- Format
- FOAM